Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

GREY:ATBPF - Post Discussion

View:
Post by Marky1 on Feb 15, 2021 11:31am

100$ stock price

Changed my sell order to sell at 100$... good for 3 months.... This is at a MC of 4B$ USD....sound

familiar? That's what Haut sold his AskBio for, and I truly think that he could duplicate that deal!

exciting week coming our way! Dan is in the pilot seat and Joe Stauffer is the copilot ....sweet
Comment by MrMugsy on Feb 15, 2021 11:40am
With full dilution of share Marky ... and a roll-in of the patents ... best consider a higher number of shares. Just to keep it simple, I'm using 60M shares going forward (for all my calculations).
Comment by Marky1 on Feb 15, 2021 11:51am
Great point,,, but the 4B$ is USD.....So actually, the MC would be Over 5B$ CDN....I think that a fair stock count would be 50 M. up from its 38.6M as shown on TD Waterhouse page....So, the 2 numbers together give you 100$ a share....no?
Comment by MrMugsy on Feb 15, 2021 11:56am
Good point on the USD amount. Now look on page 31 of the company presentation to calculate a fully diluted number. Then make sure you add a reasonable number for an AH roll-in (10-15 percent) is my guess. Now we're much closer to 60M shares. Don't forget future options, RSUs, etc ...
Comment by Marky1 on Feb 15, 2021 12:57pm
So, if I plug in your 60,000,000 shares at a MarketCap of 5B$ CDN.....I now get 85$  ,....I'm thinking maybe Dr. Haut may negotiate at a higher price than 4B$ usd....much much more iMHO
Comment by crow27 on Feb 15, 2021 1:51pm
Lets think about this again.   Dec 18/20 NR, they are working on combining AH with ATE. This is what I am thinking but I could be wrong so correct me if I am. The holding company (AH) is worth something (it has a dollar value) and it is a totally separate company from ATE. The holding company has shares and no one seems to know exactly how many but lets say it's 15 million shares. The ...more  
Comment by MrMugsy on Feb 15, 2021 2:03pm
You are right Crow. For us to cointinue and develop the first three drugs, there is no additional value to 2030/32. The additional value comes here ... There is additional value if we can get new IP for additional years of protection. There is additional value if they can create new IP for new drugs. They are working hard "right now" to find carriers and to increase AH's value. If ...more  
Comment by crow27 on Feb 15, 2021 2:32pm
Thanks Mugs, People are always concerned of how many AH shares there are but that is irrelevent to ATE shareholders That AH share count is only important to the owners of AH when they split the proceeds of a sale. They could of actually had it in a percentage instead of a share count. Means nothing to us. What is the most important is the dollar value they are asking and if it is fair to ask that ...more  
Comment by MrMugsy on Feb 15, 2021 3:38pm
---------- Exactly - has to be fair and to your point, we do need each other.  ATE wants to monetize more than just pain meds to 2030/32 if it can ... and ... AH wants to monetize the full value of AH.  It becomes a win-wn. I can only tell you about the discussions I had in the past with ATE. It led me to a 10-15% dilution as a possible range. That's obviously before the Board got ...more  
Comment by Marky1 on Feb 15, 2021 3:49pm
As you said, it leads you to 15% dilution......That brings the total stock count to roughly 44.5 M shares. How do you account for the other 15.5 M shares to get to 60M.....Please educate me
Comment by MrMugsy on Feb 15, 2021 4:57pm
Marky - page 31 of the presentation will guide you.  You have shares, you have options and RSUs, you have warrants. Then you have to think about other dilutions like future RSUs and options for the team. ----- Hope that helps
Comment by Marky1 on Feb 15, 2021 5:06pm
Sure does! I thank you
Comment by Pragmatist on Feb 15, 2021 3:47pm
People are always concerned of how many AH shares there are but that is irrelevent to ATE shareholders That AH share count is only important to the owners of AH when they split the proceeds of a sale. They could of actually had it in a percentage instead of a share count. Means nothing to us. What is the most important is the dollar value they are asking and if it is fair to ask that amout. We ...more  
Comment by crow27 on Feb 15, 2021 4:03pm
And If they took shares in ATE then the higher the share price of ATE then the less dilution. AH still gets the same dollar value but with less shares at a higher price. This is where the tires hit he pavement folks. ATE is going to be worth billions with a B. All these moving puzzle pieces are starting to come together.
Comment by Marky1 on Feb 15, 2021 4:05pm
Love your optimism Crow....Of course, I totally agree!
Comment by JimmyJ on Feb 15, 2021 5:20pm
I think most investors have already included the dilution of ATE and AH into the current value.  As you said, if the investor believes ATE pay a fair market price plus some goodwill, I don't see this affecting the sp at all negatively.  The current MC is about $225m.  What percentage of that would you say is attributed to our current exclusive to the AH IP? l10, 20, 50%?   ...more  
Comment by Pragmatist on Feb 15, 2021 7:10pm
I think you are  right in saying that the cost of consolidation will not affect SP.  There are too many other positive things at play and SHs currently are not overly concerned about it. Other factors are driving the SP.   I believe that Holdings currently gets 15% of Antibe's take of the royalties and 10% of specific milestone payments for a licensing deal.  So ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities